Primary sclerosing cholangitis and ulcerative colitis-associated neoplasia in Asia: optimizing beyond risk recognition
Intestinal Research · 31.10.2026 · 24 (4) · 607-609
DOI: 10.5217/ir.2026.00286 ↗Kurz gefasst
Editorial in der Zeitschrift Intestinal Research, erschienen am 31.10.2026. Verfasst von Ji Young Chang. Beteiligte Einrichtung: Health Promotion Center, Ewha Womans University Seoul Hospital, Seoul, Korea. lidia0826@hanmail.net. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Health Promotion Center, Ewha Womans University Seoul Hospital, Seoul, Korea. lidia0826@hanmail.net.
Zitieren
APA
Chang, J. Y. (2026). Primary sclerosing cholangitis and ulcerative colitis-associated neoplasia in Asia: optimizing beyond risk recognition. Intestinal Research, 24(4), 607-609. https://doi.org/10.5217/ir.2026.00286
Vancouver
Chang JY. Primary sclerosing cholangitis and ulcerative colitis-associated neoplasia in Asia: optimizing beyond risk recognition. Intestinal Research. 2026;24(4):607-609. doi:10.5217/ir.2026.00286
BibTeX
@article{Chang2026,
author = {Chang, Ji Young},
title = {Primary sclerosing cholangitis and ulcerative colitis-associated neoplasia in Asia: optimizing beyond risk recognition},
journal = {Intestinal Research},
year = {2026},
volume = {24},
number = {4},
pages = {607--609},
doi = {10.5217/ir.2026.00286}
}
EUVIMED